Presenting the latest research findings from the annual meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...

The final, formatted version of the article will be published soon. Relapsing Multiple Sclerosis (RMS) is characterized by neuroinflammation and neurodegeneration, leading to disability. Ofatumumab ...

Abstract: Neurogliomas are among the most aggressive forms of can-cer, presenting considerable challenges in both treatment and monitoring due to their unpredictable biological behav-ior. Magnetic ...

Abstract: Brain structural magnetic resonance image (MRI) is a very useful way to learn about the structure and function of the brain. For doctors, finding and classifying brain tumor (BT) is a ...

Background: Multiple sclerosis (MS) is a chronic autoimmune and neurodegenerative disease that often causes cognitive impairment. This study aimed to investigate the association between MS and the ...

A new study led by the University of Toronto (U of T) has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why. Researchers found that inflammation in the brain disrupts the energy supply of ...

Jennifer Worman is a fashion influencer. But this past November, she traded her usual luxury look for a hospital gown in downtown Chicago. She got a full-body MRI – something many celebrities have ...

Obtaining clearer functional MRI data about the brain and its disorders is possible using artificial intelligence, according to Boston College researchers who report in Nature Methods that they have ...